Coordinated care can improve prescribing practices of recommended diabetes, CVD therapies

By Katie Kalvaitis
NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.

“High-intensity statins, ACE inhibitors and angiotensin receptor blockers, and SGLT2 inhibitors and GLP-1 receptor agonists are all proven to improve outcomes for patients with type 2 diabetes and ASCVD,” Neha J. Pagidipati, MD, MPH, associate professor in the division of cardiology at Duke University School of Medicine and member of the Duke Clinical Research Institute, said during a late-breaking clinical trial presentation at the American College of Cardiology Scientific Session.
Read the full article in Healio.